Carmell Therapeutics Raises $4M in Series B Funding

▤ Summary

Carmell Therapeutics, a Pittsburgh, PA-based biotechnology company focused on developing and commercializing regenerative medicine technologies, closed a $4M Series B financing.The company will use the funds to advance its first product candidate, Bone Healing Accelerant, to phase III clinical development.Founded as a spin out from Carnegie Mellon University in Pittsburgh, PA, Carmell is a biotechnology company focused on developing and commercializing regenerative medicine technologies.It has created a patented technology based on biologically-active materials manufactured from human blood plasma.The regenerative materials can be manufactured to fit multiple forms, such as putties, pastes, scaffolds, plugs, screws and sheets.

▦ Linked Companies